ACER THERAPEUTICS INC (ACER) Stock News

Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant

Bayer's Phase 3 study OASIS 3 findings on elinzanetant, a promising non-hormonal treatment for menopausal hot flashes. Results show significant reduction in symptoms over 12 weeks, marking a potential breakthrough in menopause management.

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals

Acer Shareholders – Please Vote Today!...

ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER

Health Care Company Zevra Therapeutics Announces Merger With Acer Therapeutics

Mentions: ZVRA

ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therapeutics, Inc. (NYSE American - AGE), Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq -

Mentions: NYSE SOVO CTG

Shareholder Alert: Ademi LLP investigates whether Acer Therapeutics Inc. has obtained a Fair Price in its transaction with Zevra

/PRNewswire/ -- Ademi LLP is investigating Acer (Nasdaq: ACER) for possible breaches of fiduciary duty and other violations of law in its transaction with...

Shopify (SHOP) Stock Jumps 6% on Amazon Deal

Shopify (SHOP) stock is on the rise Thursday as investors react to a deal between it and e-commerce giant Amazon (AMZN).

Mentions: SHOP AMZN PLTR AXLA

ACER Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Acer Therapeutics Inc. Is Fair to Shareholders

Why Is Axcella Health (AXLA) Stock Down 21% Today?

Axcella Health (AXLA) stock is falling on Thursday following a rally from its announcement of a new Covid-19 treatment patent.

Mentions: AXLA NCNC ICCT

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq -

Mentions: SOVO CTG DBTX ZVRA ...

Why Is Acer Therapeutics (ACER) Stock Up 85% Today?

Acer Therapeutics (ACER) stock is taking off on Thursday after the company announced an acquisition deal with Zevra Therapeutics (ZVRA).

Mentions: ZVRA NCNC ICCT

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for another breakdown of the biggest pre-market stock movers as we dive into all of the latest news for Thursday!

Mentions: ICCT NCNC ALLR SATX ...

Acer Therapeutics will reacquire OLPRUVA rights from Relief Therapeutics (NASDAQ:ACER)

Pharmaceutical company Acer Therapeutics (ACER) will reacquire worldwide development, commercialization and economic rights to OLPRUVA (sodium phenylbutyrate) from Relief...

Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe

NEWTON, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development...

Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

OLPRUVA™ (sodium phenylbutyrate) kits now available in all dosage strengths and ready to ship to patients...